Cassava Sciences | PTIE - Kısa Vadeli Yükümlülükler





Kısa Vadeli Yükümlülükler Değişiklik Tarih
Abbott USD 18.38B 1.88B 2026-03
Amgen USD 24.96B 534M 2026-03
Biogen USD 3B 350.5M 2026-03
Cara Therapeutics USD 11.04M 2K 2025-12
Cassava Sciences USD 40.11M 3.72M 2026-03
Eisai JPY 340.25B 47.42B 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Geron USD 73.57M 40.25M 2026-03
J&J USD 57.72B 3.59B 2026-03
Merck USD 26.94B 1.38B 2026-03
Novartis USD 31.37B 4.1B 2026-03
Novavax USD 342.46M 117.49M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Roche Holding CHF 28B 421M 2025-12